SEER Stock Recent News
SEER LATEST HEADLINES
Squarepoint Ops LLC reduced its position in shares of Seer, Inc. (NASDAQ:SEER – Free Report) by 46.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 29,156 shares of the company’s stock after selling 25,168 shares during the quarter. Squarepoint Ops LLC’s holdings in Seer were worth $67,000 as of its most recent filing with the Securities & Exchange Commission. Several other institutional investors also recently bought and sold shares of the company. Two Sigma Advisers LP increased its holdings in Seer by 24.2% during the 4th quarter. Two Sigma Advisers LP now owns 681,900 shares of the company’s stock worth $1,575,000 after purchasing an additional 132,800 shares during the period. OMERS ADMINISTRATION Corp bought a new position in Seer in the fourth quarter worth approximately $114,000. Millennium Management LLC raised its stake in Seer by 9.1% in the fourth quarter. Millennium
Does Seer, Inc. (SEER) have what it takes to be a top stock pick for momentum investors? Let's find out.
First-of-its-kind study will use Seer's next-generation workflow to identify early-onset cancer biomarkers and power deep, unbiased mass spectrometry-based proteomics
REDWOOD CITY, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced the launch of its new Proteograph® Product Suite, featuring the Proteograph ONE Assay and SP200 Automation Instrument—its most advanced solution yet for scalable, high-resolution, mass spec-based proteomics.
Seer, Inc. (NASDAQ:SEER ) Q1 2025 Results Conference Call May 13, 2025 4:30 PM ET Company Participants Kelly Gura - Investor Relations Omid Farokhzad - Chief Executive Officer and Chair of the Board David Horn - Chief Financial Officer and President Conference Call Participants Rachel Vatnsdal - JPMorgan Operator Good day, and thank you for standing by. Welcome to Seer first quarter 2025 earnings conference call.
Seer, Inc. (SEER) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.32 per share a year ago.
Revenue grew 37%, driven by increased product sales and service revenue Revenue grew 37%, driven by increased product sales and service revenue
REDWOOD CITY, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the first quarter 2025 on Tuesday, May 13, 2025.
SEER Engages First Block AI to Assist in its Carbon Division Launch and Funding as well as Develop and Create SEER Security and Utility Tokens Backed by Assets and Fully-Insured Biochar Carbon Credits Broomfield, CO, March 31, 2025 (GLOBE NEWSWIRE) -- Strategic Environmental & Energy Resources, Inc. (SEER) (OTCQB: SENR), forms SEER Carbon Corp. as the entity to spearhead efforts to produce in-house biochar utilizing a patented technology under license from Biochar Now (www.biocharnnow.com) and create high-integrity, fully-insured carbon credits. SEER will transfer certain assets to SEER Carbon Corp. and then raise equity and growth capital through the sale of SEER Carbon security tokens.
The heavy selling pressure might have exhausted for Seer (SEER) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.